Detalhe da pesquisa
1.
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study.
J Neurol Neurosurg Psychiatry
; 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38569872
2.
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable.
Brain
; 146(11): 4633-4644, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37369086
3.
Comparing Natural History of Early and Late Onset Pediatric Multiple Sclerosis.
Ann Neurol
; 91(4): 483-495, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35150168
4.
Risk of secondary progressive multiple sclerosis after early worsening of disability.
J Neurol Neurosurg Psychiatry
; 94(12): 984-991, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414538
5.
Disability accrual in primary and secondary progressive multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 94(9): 707-717, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37068931
6.
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis.
Mult Scler
; 29(7): 875-883, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36851894
7.
Comparative effectiveness in multiple sclerosis: A methodological comparison.
Mult Scler
; 29(3): 326-332, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36800908
8.
Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis.
Eur J Neurol
; 30(4): 1014-1024, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36692895
9.
Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study.
Brain
; 145(8): 2796-2805, 2022 08 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35325059
10.
Unmet needs and gaps in the identification of secondary progression in multiple sclerosis: a Southern Italy healthcare professionals' perspective.
Neurol Sci
; 44(1): 45-58, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36114980
11.
Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS.
Mult Scler
; 28(11): 1752-1761, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35373638
12.
Two-year macular volume assessment in multiple sclerosis patients treated with fingolimod.
Neurol Sci
; 42(2): 731-733, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33033898
13.
Incidence of multiple sclerosis in the province of Catania. A geo-epidemiological study.
Environ Res
; 182: 109022, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31883496
14.
Prevalence and Incidence of Multiple Sclerosis in the City of Biancavilla.
Neuroepidemiology
; 53(1-2): 108-114, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31170722
15.
Prognostic indicators in pediatric clinically isolated syndrome.
Ann Neurol
; 81(5): 729-739, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28439957
16.
Multiple Sclerosis Progression and Relapse Activity in Children.
JAMA Neurol
; 81(1): 50-58, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38010712
17.
Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study.
Neurotherapeutics
; : e00363, 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38714462
18.
Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry.
J Neurol
; 271(3): 1150-1159, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38135850
19.
Moving forward through the in silico modeling of multiple sclerosis: Treatment layer implementation and validation.
Comput Struct Biotechnol J
; 21: 3081-3090, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37266405
20.
Boosting multiple sclerosis lesion segmentation through attention mechanism.
Comput Biol Med
; 161: 107021, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37216775